Pharmacology & ToxicologybioRxivPreprint
Tocilizumab induces significant changes in longitudinal proteomes of blood serum from patients with severe COVID-19 pneumonia
José Cordero, Graciela Bravo, Pedro H. Silva…·Jaime Retamal
This study shows that tocilizumab reduces inflammation in severe COVID-19 by altering serum proteomes, restoring protein levels to healthy states.
DOI 10.64898/2026.05.05.723025